| Trial Identifier: | D8230C00002 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel International
|
| Start Date: | February 2021 |
| Primary Completion Date: | September 2023 |
| Study Completion Date: | February 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Spanish Translation | |
| Spanish (United States) Translation | |
| French Translation | |
| Korean Translation | |
| Polish Translation |
| Country | Location |
|---|---|
| AU | Clayton, AU, 3168 |
| AU | Nedlands, AU, 6009 |
| CA, QC | Quebec, QC, CA, G1R 2J6 |
| ES | Barcelona, ES, 08035 |
| ES | Palma de mallorca, ES, 07120 |
| FR | Lille, FR, 59037 |
| GB | Plymouth, GB, PL6 8DH |
| IE | Dublin, IE, D08 NHY1 |
| IE | Galway, IE, H91 YR71 |
| KR | Seoul, KR, 06351 |
| KR | Seoul, KR, 05505 |
| KR | Seoul, KR, 03080 |
| PL | Kraków, PL, 30-510 |
| US, CA | Duarte, CA, US, 91010 |
| US, California | La Jolla, California, US, 92093-0052 |
| US, TX | Houston, TX, US, 77030 |
| US, UT | Salt Lake City, UT, US, 84112 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company